Dr. Loven is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 Bluebird Dr
Goodlettsville, TN 37072Phone+1 615-859-7546Fax+1 615-851-7760
Education & Training
Virginia Commonwealth University Health SystemResidency, Dermatology, 1984 - 1987
Indiana University School of MedicineInternship, Internal Medicine, 1983 - 1984
Vanderbilt University School of MedicineClass of 1983
Certifications & Licensure
TN State Medical License 1987 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top MD Consumers Checkbook
- Fellow (FAAD) American Academy of Dermatology
- Join now to see all
Clinical Trials
- Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2014 Apr 01
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
- Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsTazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.Emil Tanghetti, William Abramovits, Barry A. Solomon, Keith Loven, Alan R. Shalita
Journal of Drugs in Dermatology. 2006-03-01 - 35 citationsLong‐Term Clinical Outcomes Following Treatment of Actinic Keratosis with Imiquimod 5% CreamPeter K. Lee, William B. Harwell, Keith H. Loven, Tania J. Phillips, David A. Whiting
Dermatologic Surgery. 2005-06-01 - 17 citationsTazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.Alan R. Shalita, B Miller, A Menter, William Abramovits, Keith Loven
Journal of Drugs in Dermatology. 2005-03-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
